Julie A. Margenthaler, MD

“Lymphedema represents a significant morbidity for patients who experience it,” commented Julie A. Margenthaler, MD, of Washington University School of Medicine, St. Louis. “This study [PREVENT] demonstrates that bioimpedance spectroscopy can identify early signs of lymphedema, so interventions can be taken to prevent its progression. This is an important step in improving the lives of our breast cancer survivors.” ■

DISCLOSURE: Dr. Margenthaler reported no conflicts of interest.